Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC

Volume: 24, Issue: 8, Pages: 2224 - 2232
Published: Mar 6, 2017
Abstract
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a combined treatment option for well-selected patients with peritoneal carcinomatosis (PC). The study aimed to identify factors influencing cancer-specific survival (CSS) and disease-free survival (DFS). Data of 113 patients with colorectal or appendicular carcinomatosis from a single center operated between 2009 and 2014 were retrospectively collected and...
Paper Details
Title
Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC
Published Date
Mar 6, 2017
Volume
24
Issue
8
Pages
2224 - 2232
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.